NAC treatment attenuates the development of hypertension in young SHRs, which is correlated with a reduction in plasma ADMA levels, a decrease in superoxide production, an increase in DDAH activity, and an increase in GSH to oxidized GSH ratio in the SHR kidney [28]. This evidence concerns the gene DDAH1 and Hypertension.